DNA RNA and Cells
31 March 2016
Ionis Pharmaceuticals Advances Nusinersen in the Ongoing SHINE Study in Patients with SMA31 March 2016
SpinalCyte, LLC Announces New Results from Phase II Animal Trials of Cell Therapy to Regenerate the Spinal Disc23 March 2016
Regen BioPharma, Inc. Submits IND Application to FDA on tCellVax, a Checkpoint Inhibitor for Cancer Therapy23 March 2016
uniQure Announces Preclinical Proof of Concept for Gene Therapy Approach in Huntington’s Disease22 March 2016
Oncolytics Biotech® Inc. Reports Data from Randomized Phase 2 Study of REOLYSIN® in Ovarian Cancer21 March 2016
RetroSense Therapeutics Doses First Patient in Phase I/II Clinical Trial for Lead Compound RST-00114 March 2016
Ritter Pharmaceuticals Initiates Phase 2B/3 Clinical Trial of RP-G28 in Lactose Intolerance14 March 2016
Sylentis Reports Positive Phase II Results With SYL1001 in Treating Ocular Pain Related to Dry Eye Syndrome14 March 2016
Alnylam Initiates Fitusiran (ALN-AT3) Dosing in Hemophilia A and B Patients with Inhibitors in Ongoing Phase 1 Study14 March 2016
uniQure Announces Dosing of First Patient in High-Dose Cohort in Phase I/II Hemophilia B Clinical Trial10 March 2016
PsiOxus Therapeutics Initiates Combination of Paclitaxel with Oncolytic Virus Enadenotucirev in Ovarian Cancer Study7 March 2016
International Stem Cell Corporation Announces Commencement of Enrollment of Phase I Trial of ISC-hpNSC26 February 2016
Update on TT-034 Hepatitis C Clinical TrialNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports